Skin Cancer

The AJMC® Skin Cancer compendium is a comprehensive resource for clinical news and expert insights about melanoma and other skin cancers.

Latest News
October 16th 2024

Community Engagement, Culturally Tailored Care as a Gateway to Advancing Health Equity

June 28th 2024

FDA-Approved Red-Light LED Lamp Released for Patients With Actinic Keratosis

June 28th 2024

Certain Melanoma Subtype May Be More Sensitive to NK, T Cells

June 20th 2024

Further Medicaid Expansion Would Benefit Patients With Melanoma, Study Finds

June 15th 2024

Management of Melanoma During Pregnancy Explored at ASCO 2024

Dr. Jason Luke leads a panel discussing immunotherapy advances in Cutaneous and Basal Cell Carcinoma

Watch the series now!

Join a panel of leaders as they discuss treatment for patients diagnosed with metastatic NSCLC without driver mutations
Video Interviews
View All
December 5th 2022

Dr Neil Gross: Cemiplimab Has Great Potential in cSCC

November 12th 2022

Dr Neil Gross on Potential Impact of Future Novel Treatments for cSCC

November 2nd 2022

Dr Neil Gross Discusses the Implications of pCR on Additional Treatment in Skin Cancer

October 20th 2022

Dr Neil Gross: QOL Improvement Likely Following Treatment With Cemiplimab for cSCC

October 3rd 2022

Dr Neil Gross: Cemiplimab Is Producing Encouraging Results in Resectable cSCC

October 4th 2021

Dr Christine Ko on Making Tough Skin Cancer–Related Decisions for Transplant Patients

September 28th 2021

Dr Todd Schlesinger: Tissue-Sparing Mohs Surgery Is Highly Accurate

September 10th 2021

Dr Christine Ko: Transplant Patients Face Unique Skin Cancer Risks

September 5th 2021

Dr Todd Schlesinger on How Medical, Cosmetic, Research Dermatology Interact

August 19th 2021

Dr Todd Schlesinger: Morphology, Immunosuppression Affect Actinic Keratosis Outcomes

More News

Skin cancer risk may be associated with immunosuppressant medication, although multiple studies exploring this relationship have not drawn concrete conclusions | image credit: Damian Gretka - stock.adobe.com
June 13th 2024

Link Between Skin Cancer and Immunosuppressants Needs Further Research

Kyle Munz
At the 2024 American Society of Clinical Oncology annual meeting, an abstract presenting real-world data stressed the need for further research regarding the association between immunosuppressant medication and the development of skin cancer.
Skin cancer checkup concept with cancer ribbon | image credit: Monstar Studio - stock.adobe.com
June 10th 2024

Metformin for Melanoma Holds Potential Benefits for Patients

Kyle Munz
Metformin showed promise for improving the overall survival rate of patients with melanoma; however, this result may be an indirect consequence of the drug.
Skin cancer screening | Image credit: Viktoriia - stock.adobe.com
May 31st 2024

Keratinocyte Cancers Most Commonly Located on the Head and Neck, US Study Finds

Rose McNulty
A large Medicare cohort study found that the most common locations of procedurally treated keratinocyte cancers in the US were the head and/or neck for both squamous cell carcinomas and basal cell carcinomas.
Person Operating Smartphone | image credit: Production Perig - stock.adobe.com
May 31st 2024

Concerns About AI-Based Dermatologic Mobile Apps

Kyle Munz
An analysis that overviewed dermatologic mobile apps with artificial intelligence (AI) features led researchers to voice concerns about the use of this technology in its current state.
Clinician Marking Non-melanoma Skin Cancer Lesion for Removal | image credit: Pixel-Shot - stock.adobe.com
May 13th 2024

Patients With Nonmelanoma Skin Cancer Prefer RSCT Over Surgery

Kyle Munz
A follow-up study utilizing interviews and survey responses demonstrates that patients prefer rhenium-188 skin cancer therapy (RSCT) over surgery in the treatment of their non-melanoma skin cancer.
Adverse Drug Reaction Warning | image credit: Balint Radu - stock.adobe.com
May 9th 2024

Patients With Advanced, Recurrent Melanoma May Experience Lasting AEs From ICM Therapy

Kyle Munz
A cross-sectional, mixed-methods study found that adverse effects (AEs) can occur even after 1 year of treatment with immune checkpoint modulator (ICM) therapy in patients with melanoma.
Basal Cell Carcinoma | image credit: Laura Ballard - stock.adobe.com
May 3rd 2024

Exploration Into Super-Giant Basal Cell Carcinoma Calls for Future Research

Kyle Munz
A systematic analysis demonstrated the rarity of super-giant basal cell carcinomas and the need for further characterization of these understudied skin cancers.
Skin cancer check | Image credit: InsideCreativeHouse - stock.adobe.com
April 30th 2024

Survivors of Early-Stage Melanoma Have High Rates of Fear of Recurrence, Study Finds

Rose McNulty
The study aimed to improve the understanding of lived experiences and the fear of recurrence among survivors of localized, stage 0 to IIA cutaneous melanoma.
Skin Check for Melanoma | image credit: cunaplus - stock.adobe.com
April 26th 2024

Exploration of Melanoma Incidence, Mortality Rates Urges Further Research

Kyle Munz
A retrospective analysis out of Denmark could not find a causal relationship to explain trends in melanoma incidence and mortality rates, demonstrating the need for more research in this area.
AI-Generated CT Equipment Concept | image credit: StraSyP - stock.adobe.com
April 15th 2024

Dr Michael Farwell on FDG PET/CT Imaging to Predict Immunotherapy Response in Advanced Melanoma

Kyle Munz
Michael Farwell, MD, associate professor of radiology at the Hospital of the University of Pennsylvania, provides insights into a study on the benefits of using 18F-fluorodeoxyglucose (FDG) PET/CT imaging to detect metabolic tumor changes in skin cancer.
AI-Based Smartphone App Proves Reliable in Diagnosis of Melanoma
April 9th 2024

AI-Based Smartphone App Proves Reliable in Diagnosis of Melanoma

Kyle Munz
A prospective study evaluating the efficacy of an artificial intelligence (AI)–based clinical support system further demonstrated the reliability of AI or machine learning as a diagnostic tool in skin cancer.
Cancerous Cells Concept | image credit: Dr_Microbe - stock.adobe.com
April 5th 2024

Yes-Associated Protein May Hold Prognostic Value in Cutaneous Melanoma

Kyle Munz
A retrospective study analyzing tissue assays from patients with cutaneous melanoma demonstrated the promise of yes-associated protein (YAP) as a predictive biomarker for melanoma prognosis.
Collaboration With AI Concept | image credit: ipopba - stock.adobe.com
March 30th 2024

AI Accurately Predicts Skin Cancer Risk Based on 2D Facial Images

Kyle Munz
An artificial intelligence (AI) mode was more accurate in assessing patient risks for skin cancer through the analysis of 2D facial images compared with more traditional risk-factor screening.
Man Prior to Skin Examination | image credit: New Africa - stock.adobe.com
March 28th 2024

Risk for Second Primary Melanoma Increases After Primary Melanoma Diagnosis as Men Age

Kyle Munz
A population-based cohort study out of Norway has found that older men have a higher risk of developing second primary invasive melanoma following an initial primary melanoma, suggesting the benefits of increased surveillance in these patients.
Radiation Therapy Model | image credit: Andrii - stock.adobe.com
March 26th 2024

Radiation Therapy Associated With Elevated Skin Cancer Risk in Patients With Breast Cancer

Kyle Munz
Results from a retrospective cohort study analyzing patients with breast cancer bolster reports of an association between radiation therapy and subsequent risks of skin cancers.
AI Chip | Image credit: Shuo - stock.adobe.come
March 16th 2024

Federated Learning Models Show Potential in Melanoma-Nevus Classification, but Improvements Needed

Kyle Munz
A multicentric, single-arm diagnostic study created a decentralized federated learning model for the classification of invasive melanomas and nevi, showcasing comparable results to centralized data models.
Woman Checking Skin for Signs of Melanoma | image credit: MW Photography - stock.adobe.com
March 14th 2024

Use of Immunohistochemistry in Melanoma Diagnosis Has Grown, but More Research Is Needed

Kyle Munz
A retrospective, cross-sectional study analyzed national trends of immunohistochemistry (IHC) use in the diagnosis of melanoma.
Guidelines Spelled in Blocks | image credit: chrupka - stock.adobe.com
March 8th 2024

More Research Needed to Address Discordance in Skin Cancer Treatment Guidelines

Kyle Munz
A comparative analysis on skin cancer management guidelines in the US highlights the necessity of further research in this subject.
Melanoma on Skin | image credit: Ocskay Mark - stock.adobe.com
February 29th 2024

Skin Cancer Overdiagnosis in White Americans Is Increasing, Study Says

Kyle Munz
An ecological study revealed increasing rates of skin cancer overdiagnosis in white Americans.
AI Display Concept | image credit: Tierney - stock.adobe.com
February 21st 2024

Skin Cancer Treatment Landscape Is Evolving With AI

Kyle Munz
Andrew Ress, MD, discusses the novel integration of artificial intelligence (AI) into the skin cancer treatment landscape.
Preventative Melanoma Screening | image credit: sofiko14
February 13th 2024

Clinical Data Lacking on Black Patients With Melanoma

Kyle Munz
A single-institution, retrospective cohort study evaluates knowledge gaps in clinical data on Black patients with melanoma.
Genome Sequencing Model | image credit: catalin - stock.adobe.com
February 7th 2024

Predisposition to Early-Onset Merkel Cell Carcinoma Linked to Genetic Variants

Kyle Munz
A case-control study found that patients with early-onset Merkel cell carcinoma exhibited genetic variations associated with the development of their disease.
Clinician Performing Skin Examination | image credit: Peakstock - stock.adobe.com
February 6th 2024

Stigma, Discrimination Impact Sexual and Gender Minority Perspectives on Full-Body Skin Examinations, Study Finds

Kyle Munz
A survey revealed the influence of prior stigmatic or discriminatory experiences on sexual and gender minority (SGM) patients’ perceptions of screening for skin cancer, stressing the need for affirming clinical settings.
Piggy Bank With Stethoscope | image credit: Nudphon - stock.adobe.com
February 1st 2024

40-GEP Test Utilization Can Mitigate Financial Burden of Cutaneous Squamous Cell Carcinoma

Kyle Munz
Medicare-eligible patients with cutaneous squamous cell carcinoma (cSCC) could save on health care costs by utilizing the 40-gene expression profile (40-GEP) to guide treatment decisions.
Hair Color Spectrum | image credit: Elvira - stock.adobe.com
January 23rd 2024

Natural Hair Color Identified as Potential Skin Cancer Risk Factor

Kyle Munz
Results from a meta-analysis suggest a correlation between natural hair color and the development of skin cancer.
Skin Examination | image credit: thodonal - stock.adobe.come
January 18th 2024

Phase 3 Data Show Long-Term Survival Benefit of Tebentafusp in Metastatic Uveal Melanoma

Kyle Munz
An international, open-label trial demonstrated the overall survival benefits of administering tebentafusp to HLA-A*02:01-positive patients with metastatic uveal melanoma.
what we're reading logo
January 18th 2024

What We’re Reading: New Prior Authorization Limits; Veteran Suicide Prevention Program; AI Skin Cancer Detector

AJMC Staff
CMS has announced new federal rules that require health insurers to streamline requests to cover treatments; nearly 50,000 veterans used the emergency suicide prevention program launched by the Department of Veteran Affairs in 2023; the FDA recently authorized the first artificial intelligence (AI)-powered medical device to help doctors detect the most common forms of skin cancer.
Ultraviolet Light Model | image credit: Sergey Ryzhov - stock.adobe.com
January 12th 2024

Ultraviolet Phototherapy Without Psoralens Does Not Increase Risk of Skin Cancer, Study Suggests

Kyle Munz
A retrospective cohort study found no significant associations between phototherapy without psoralens and the risk of skin cancer.
Melanoma on Skin | Image credit: Ocskay Mark - stock.adobe.com
January 11th 2024

Patients With Regressive Melanoma Eligible for Sentinel Lymph Node Biopsy May Have Better Outcomes

Kyle Munz
A single-institutional cohort study found that in patients with melanoma, regressive status could be used as a valuable predictive marker of prognosis and response to systemic therapy.
Portrait of Native American Women | image credit: Gary - stock.adobe.com
January 9th 2024

Skin Cancer’s Impact on American Indian/Alaska Native Communities Deserves More Consideration

Kyle Munz
A retrospective study showcases the need for considering the impact of skin cancers in non-Hispanic American Indian/Alaska Native communities, who experience some of the highest incidences of melanoma in the US.
12345>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo